banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

Sonnet

Anthropic releases Claude Sonnet 4.5, a model it says can build software and accomplish business tasks autonomously

by

Anthropic has launched Claude Sonnet 4.5, its newest AI model, claiming significant advancements in autonomous work and coding. The company said that the model was able to run autonomously for 30 hours, maintaining sustained focus with minimal oversight while building an entire software application. It’s a significant improvement over the company’s previous Opus 4 model, … Read more

Anthropic launches Claude Sonnet 4.5, its latest AI model

by

Dario Amodei, co-founder and chief executive officer of Anthropic, at the World Economic Forum in 2025. Stefan Wermuth | Bloomberg | Getty Images Anthropic on Monday announced its latest artificial intelligence model: Claude Sonnet 4.5. The model is better at coding, using computers and meeting practical business needs, and it excels in specialized fields like … Read more

Anthropic launches Claude Sonnet 4.5, its best AI model for coding

by

On Monday, Anthropic launched a new frontier model called Claude Sonnet 4.5, which it claims to offer state-of-the-art performance on coding benchmarks. The company says Claude Sonnet 4.5 is capable of building “production-ready” applications, rather than just prototypes, representing a leap in reliability from previous AI models. Claude Sonnet 4.5 will be available via the … Read more

Sonnet ditches biotech dreams to anchor a $583m HYPE token reserve

by

Sonnet BioTherapeutics is no longer just a cancer drug developer. Its $888 million merger will place it among the largest HYPE holders, blurring the lines between traditional finance and decentralized protocols in a high-stakes treasury experiment. According to a July 14 press release, Nasdaq-listed biotech firm Sonnet BioTherapeutics has agreed to an $888 million business … Read more

Sonnet BioTherapeutics Skyrockets: A Biotech’s Bold Leap into Crypto with HYPE

by

Buckle up, folks, because the market’s throwing us a curveball today, and it’s called Sonnet BioTherapeutics (NASDAQ: SONN)! As of this writing, SONN is screaming higher, with its stock price surging a jaw-dropping 344% in pre-market trading, making it one of the biggest movers on the Nasdaq. What’s got Wall Street buzzing like a beehive? … Read more

Amazon-backed Anthropic debuts Claude 4 Opus and Sonnet AI models

by

In this photo illustration, Claude AI logo is seen on a smartphone and Anthropic logo on a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) Sopa Images | Lightrocket | Getty Images Anthropic, the Amazon-backed OpenAI rival, on Thursday launched its most powerful group of artificial intelligence models yet: Claude 4. The … Read more

Anthropic say Claude Sonnet 3.7 is its ‘most intelligent’ AI model yet

by

Jaque Silva | Nurphoto | Getty Images As heavily funded startups and tech giants hustle to get any lead they can in artificial intelligence, Anthropic says it’s developed the company’s “most intelligent” AI model yet. The Amazon-back startup on Monday unveiled Claude 3.7 Sonnet. What makes it unique is its so-called hybrid model, which combines … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4